– UK, London – Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces that Brian Larcombe will retire as Senior Independent Director and Non-Executive Director at the conclusion of the Annual General Meeting on 6 April 2017.
Following the Annual General Meeting on 6 April 2017, and subject to his re-election as a Director of Smith & Nephew plc at the Annual General Meeting, Ian Barlow will be appointed as the Senior Independent Non-Executive Director, in place of Brian Larcombe.
On 1 March 2017, Ian Barlow will step down as Chairman of the Audit Committee and Robin Freestone will be appointed Chairman of the Audit Committee in his place.
Roberto Quarta, Chairman, said: “Brian Larcombe has served Smith & Nephew for many years, as our Senior Independent Director since 2014, and as a member of the Audit, Nomination & Governance and Remuneration Committees. We will miss his great wisdom and experience. On behalf of the whole Board I thank him for his service and wish him well for the future.”
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping healthcare professionals improve people’s lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma & Extremities, Smith & Nephew has around 15,000 employees and a presence in more than 100 countries. Annual sales in 2015 were more than $4.6 billion. Smith & Nephew is a member of the FTSE100 (LSE:SN, NYSE:SNN).
For more information : http://www.smith-nephew.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
